Nifty

:

14330.45

Sensex

:

47961.24

-504.40 (-3.40%)
-1630.08 (-3.29%)

Login

Nifty
Sensex

:
:

14330.45
47961.24

-504.40 (-3.40%)
-1630.08 (-3.29%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

61/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

38.70

09-Apr-2021

Open
High
Low
Previous Close

35.60
39.40
35.30
35.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13279751
5008.86
39.40
13.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,743.08
21.43
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,837.32
N/A
4.91

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.09
11.95
12.04

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.07
2.17
1.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-
21.28
4.31

P:E (Median)

8 Years
5 Years
3 Years

30.58
33.52
26.43

P:BV (Average)

8 Years
5 Years
3 Years

3.89
4.54
3.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.88
14.94
13.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 290.46 213.49 36.05% 314.60 199.88 57.39% 243.26 189.47 28.39% 189.15 206.07 -8.21%
Expenses 260.35 199.71 30.36% 285.27 184.99 54.21% 217.98 170.02 28.21% 172.80 186.01 -7.10%
EBITDA 30.11 13.77 118.66% 29.33 14.90 96.85% 25.27 19.45 29.92% 16.35 20.06 -18.49%
EBIDTM 10.37% 6.45% 9.32% 7.45% 10.39% 10.26% 8.64% 9.74%
Other Income 2.84 4.60 -38.26% 3.73 2.81 32.74% 1.33 0.28 375.00% 1.72 1.03 66.99%
Interest 1.27 0.54 135.19% 0.29 0.39 -25.64% 0.29 0.42 -30.95% 0.62 0.92 -32.61%
Depreciation 7.05 7.93 -11.10% 7.15 7.63 -6.29% 7.47 10.90 -31.47% 7.97 10.95 -27.21%
PBT 24.64 9.90 148.89% 25.62 9.69 164.40% 18.84 8.41 124.02% 9.48 9.22 2.82%
Tax 0.00 0.00 0 0.00 5.15 -100.00% 0.00 0.00 0 0.00 0.00 0
PAT 24.64 9.90 148.89% 25.62 4.54 464.32% 18.84 8.41 124.02% 9.48 9.22 2.82%
PATM 8.48% 4.64% 8.14% 2.27% 7.75% 4.44% 5.01% 4.47%
EPS 0.55 0.22 150.00% 0.57 0.10 470.00% 0.42 0.19 121.05% 0.21 0.21 0.00%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 307.42 230.06 33.63% 336.39 213.43 57.61% 257.64 202.98 26.93% 206.60 218.72 -5.54%
Expenses 277.63 214.75 29.28% 304.64 198.37 53.57% 231.07 183.65 25.82% 187.78 196.97 -4.67%
EBITDA 29.79 15.30 94.71% 31.75 15.06 110.82% 26.57 19.33 37.45% 18.83 21.75 -13.43%
EBIDTM 9.69% 6.65% 9.44% 7.05% 10.31% 9.52% 9.11% 9.94%
Other Income 2.84 4.60 -38.26% 3.73 2.81 32.74% 1.33 0.28 375.00% 1.79 1.03 73.79%
Interest 1.27 0.54 135.19% 0.29 0.39 -25.64% 0.29 0.43 -32.56% 0.62 0.93 -33.33%
Depreciation 7.56 8.54 -11.48% 7.68 8.24 -6.80% 8.06 11.50 -29.91% 8.63 11.15 -22.60%
PBT 23.80 10.82 119.96% 27.52 9.24 197.84% 19.55 7.68 154.56% 11.36 10.70 6.17%
Tax 0.01 0.01 0.00% 0.35 5.15 -93.20% 0.19 0.02 850.00% 0.34 0.21 61.90%
PAT 23.79 10.82 119.87% 27.17 4.09 564.30% 19.36 7.66 152.74% 11.02 10.49 5.05%
PATM 7.74% 4.70% 8.08% 1.92% 7.52% 3.77% 5.33% 4.80%
EPS 0.53 0.24 120.83% 0.60 0.09 566.67% 0.43 0.17 152.94% 0.25 0.23 8.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,037.47 791.99 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 216.31 Net Sales Growth 28.26% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% 24.59% Cost Of Goods Sold 689.19 487.87 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 140.48 Gross Profit 348.28 304.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 75.83 GP Margin 33.57% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% 35.06% Total Expenditure 936.40 727.52 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 209.07 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% 3.56% Employee Cost - 98.07 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 26.79 % Of Sales - 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% 12.39% Manufacturing Exp. - 48.90 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 11.40 % Of Sales - 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% 5.27% General & Admin Exp. - 31.93 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 10.06 % Of Sales - 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% 4.65% Selling & Distn. Exp. - 35.75 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 8.27 % Of Sales - 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% 3.82% Miscellaneous Exp. - 12.45 11.11 16.26 22.53 7.38 6.66 6.25 6.91 3.47 8.27 % Of Sales - 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% 2.02% EBITDA 101.06 64.47 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 7.24 EBITDA Margin 9.74% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% 3.35% Other Income 9.62 9.42 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 1.04 Interest 2.47 1.97 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 6.23 Depreciation 29.64 34.43 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 45.78 PBT 78.58 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Tax 0.00 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 -0.75 Tax Rate 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% 1.72% PAT 78.58 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 PAT before Minority Interest 78.58 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.57% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% -19.87% PAT Growth 145.03% 13.00% 9.53% 12.73% 46.83% 2,620.69% - - - - EPS 1.75 0.72 0.64 0.58 0.52 0.35 0.01 -0.14 -0.50 -0.54 -0.96

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,108.05 853.07 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 228.30 Net Sales Growth 28.07% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% 26.74% Cost Of Goods Sold 731.31 524.19 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 142.68 Gross Profit 376.74 328.87 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 85.62 GP Margin 34.00% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% 37.50% Total Expenditure 1,001.12 784.55 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 222.53 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% 3.37% Employee Cost - 109.91 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 30.52 % Of Sales - 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% 13.37% Manufacturing Exp. - 48.92 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 11.40 % Of Sales - 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% 4.99% General & Admin Exp. - 36.47 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 12.72 % Of Sales - 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% 5.57% Selling & Distn. Exp. - 40.11 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 11.26 % Of Sales - 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% 4.93% Miscellaneous Exp. - 12.39 13.20 18.11 29.95 9.35 7.61 7.01 7.72 5.75 11.26 % Of Sales - 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% 2.74% EBITDA 106.94 68.52 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 5.77 EBITDA Margin 9.65% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% 2.53% Other Income 9.69 9.48 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 1.04 Interest 2.47 1.98 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 6.27 Depreciation 31.93 36.91 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 48.16 PBT 82.23 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 -47.62 Tax 0.89 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 -0.69 Tax Rate 1.08% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% 1.45% PAT 81.34 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 -46.93 PAT before Minority Interest 81.34 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 -46.93 Minority Interest 0.00 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 0.00 PAT Margin 7.34% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% -20.56% PAT Growth 146.04% 16.40% -2.50% 25.22% 84.61% 498.13% - - - - EPS 1.81 0.75 0.64 0.66 0.53 0.28 0.05 -0.06 -0.46 -0.53 -1.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 307.25 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 377.26 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 217.29 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 167.65 Non-Current Liabilities 25.36 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 134.86 Secured Loans 0.92 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 22.38 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 3.75 Current Liabilities 329.38 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 103.74 Trade Payables 158.38 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 57.32 Other Current Liabilities 157.39 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 44.68 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.25 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 1.74 Total Liabilities 661.99 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 615.86 Net Block 134.84 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 416.58 Gross Block 641.54 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 896.07 Accumulated Depreciation 506.70 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 479.49 Non Current Assets 313.73 336.06 363.54 369.25 387.98 395.80 415.92 454.30 496.93 539.79 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 118.78 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 121.91 Long Term Loans & Adv. 59.83 65.49 63.47 59.41 53.92 33.93 8.51 1.58 1.55 1.30 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 348.26 283.33 227.11 178.56 146.88 104.41 91.97 87.20 85.78 76.07 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 132.47 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 33.61 Sundry Debtors 121.41 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 27.73 Cash & Bank 38.03 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 2.34 Other Current Assets 56.35 7.72 5.49 4.55 22.08 12.00 10.90 9.14 10.68 12.39 Short Term Loans & Adv. 50.45 30.80 31.53 21.67 16.27 8.89 7.94 6.56 9.00 9.61 Net Current Assets 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 -27.67 Total Assets 661.99 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71 615.86

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 284.06 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 344.05 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 194.10 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 134.44 Non-Current Liabilities 28.42 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 135.01 Secured Loans 0.92 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 23.82 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 3.90 Current Liabilities 351.44 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 102.78 Trade Payables 172.30 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 59.79 Other Current Liabilities 165.06 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 41.11 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.72 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 1.88 Total Liabilities 663.46 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 Net Block 216.37 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 496.02 Gross Block 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 997.96 Accumulated Depreciation 536.18 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 501.94 Non Current Assets 291.29 315.71 342.37 346.34 366.53 374.42 393.18 415.00 457.37 501.38 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 1.08 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 3.97 Long Term Loans & Adv. 73.55 79.22 77.81 73.69 69.82 51.94 25.10 1.67 1.64 1.39 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 372.18 299.47 243.44 191.95 157.15 114.58 96.32 91.09 89.61 80.02 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 138.48 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 34.70 Sundry Debtors 137.68 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 29.64 Cash & Bank 38.88 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 2.58 Other Current Assets 57.14 7.86 5.62 4.71 22.71 12.48 11.24 9.40 11.29 13.10 Short Term Loans & Adv. 51.16 31.43 32.92 22.03 16.77 9.34 8.23 6.23 9.60 10.30 Net Current Assets 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 -22.76 Total Assets 663.47 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 10.86 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 9.67 PBT 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Adjustment 34.23 38.36 37.86 40.92 45.32 47.22 55.66 56.73 54.84 52.00 Changes in Working Capital -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 0.65 Cash after chg. in Working capital 16.38 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 8.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 0.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 0.00 Cash From Investing Activity -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 -3.85 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 -1.44 Cash from Financing Activity 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 -4.30 Net Cash Inflow / Outflow 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 1.52 Opening Cash & Equivalents 9.36 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 0.82 Closing Cash & Equivalent 12.79 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96 2.34

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 11.02 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 11.13 PBT 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 -35.61 -47.62 Adjustment 36.63 40.32 38.64 41.40 45.69 47.32 55.76 56.80 55.99 54.44 Changes in Working Capital -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 3.63 Cash after chg. in Working capital 16.89 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 10.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 0.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 -4.05 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 -1.64 Cash from Financing Activity 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 -5.60 Net Cash Inflow / Outflow 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 1.48 Opening Cash & Equivalents 9.60 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 1.10 Closing Cash & Equivalent 13.64 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51 2.58

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.83 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 5.73 ROA 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% -6.81% ROE 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% -15.44% ROCE 9.29% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% -7.02% Fixed Asset Turnover 1.12 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 0.25 Receivable days 56.08 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 40.17 Inventory Days 51.46 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 53.30 Payable days 79.07 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 97.16 Cash Conversion Cycle 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 -3.69 Total Debt/Equity 0.43 0.47 0.53 0.22 0.20 0.26 0.27 0.34 0.34 0.35 Interest Cover 20.05 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04 -6.02

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.32 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 4.99 ROA 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% -7.84% ROE 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% -18.99% ROCE 10.25% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% -8.22% Fixed Asset Turnover 1.04 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 0.23 Receivable days 58.07 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 42.17 Inventory Days 49.78 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 52.36 Payable days 79.06 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 101.91 Cash Conversion Cycle 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 -7.39 Total Debt/Equity 0.47 0.52 0.06 0.25 0.22 0.28 0.30 0.37 0.38 0.39 Interest Cover 20.71 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96 -6.59

Top Investors:

pinfold overseas limited

ferry holdings limited

life insurance corporation of india

damodar prasad agarwal

morepen laboratories limited - unclaimed suspence account

Annual Reports:

News Update:

Morepen Laboratories eyeing multi-billion dollar global API market
12th Feb 2021, 15:03 PM

Global patent expiry for these new molecules is slated in next 5-6 years
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback